Population pharmacokinetics and limited sampling strategy for therapeutic drug monitoring of mycophenolate mofetil in Japanese patients with lupus nephritis Publication Population pharmacokinetics and limited sampling strategy for therapeutic drug monitoring of mycophenolate mofetil in Japanese patients with lupus nephritis Find out how renal function and albumin drive MPA clearance; 1–4 h sampling best predicts…Certara2023 年 1 月 9 日
Population Pharmacokinetics and Dosing Regimen Optimization of Linezolid in Cerebrospinal Fluid and Plasma of Post-operative Neurosurgical Patients Publication Population Pharmacokinetics and Dosing Regimen Optimization of Linezolid in Cerebrospinal Fluid and Plasma of Post-operative Neurosurgical Patients Explore how highly variable CSF penetration; PopPK modelling supports renal‑ and inflammation‑adjusted dosing using Phoenix…Certara2022 年 12 月 22 日
Therapeutic Proteins’ Drug-Drug Interactions: Updates & Challenges On-Demand Webinar 治疗蛋白质的药物间相互作用:最新情况与挑战 Therapeutic proteins (TP) - and more specifically monoclonal antibodies - are part of the therapeutic…Certara2022 年 12 月 5 日
Establishment of PK-PD model in anti-inflammatory active components in Inula cappa extract based on lipopolysaccharide-induced in vitro inflammation model Publication Establishment of PK-PD model in anti-inflammatory active components in Inula cappa extract based on lipopolysaccharide-induced in vitro inflammation model Discover how PK‑PD modelling shows anti‑inflammatory components reduce NO and TNF‑α in inflamed cells using…Certara2022 年 12 月 1 日
Pharmacokinetics and pharmacodynamics of polymyxin B and proposed dosing regimens in elderly patients with multi-drug-resistant Gram-negative bacterial infections Publication Pharmacokinetics and pharmacodynamics of polymyxin B and proposed dosing regimens in elderly patients with multi-drug-resistant Gram-negative bacterial infections See how fixed 50–75 mg dosing meets PK/PD targets; albumin has minor PK impact using…Certara2022 年 11 月 11 日
Pharmacokinetic and Bioequivalent Study of Potassium Chloride Sustained-Release Tablet Under Different Dietary Conditions in Healthy Chinese Subjects Publication Pharmacokinetic and Bioequivalent Study of Potassium Chloride Sustained-Release Tablet Under Different Dietary Conditions in Healthy Chinese Subjects Learn how urinary potassium excretion comparable across formulations and diets; BE confirmed using Phoenix WinNonlin.Certara2022 年 11 月 2 日
Pharmacokinetics of L-Citrulline in Neonates at Risk of Developing Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension. 刊物 Pharmacokinetics of L-Citrulline in Neonates at Risk of Developing Bronchopulmonary Dysplasia-Associated Pulmonary Hypertension. Find out how short 16‑min half‑life; simulations support 37–52 mg/kg QID dosing using Phoenix WinNonlin.Certara2022 年 10 月 31 日
Why you should select your drug formulation before starting clinical studies Blog 为何应在开始临床研究前选择药物制剂 药物开发者常急于推进发现流程以进入人体试验。Most are…Certara2022 年 10 月 28 日
Population Pharmacokinetic Analysis of Valsartan in Healthy Chinese Subjects Publication Population Pharmacokinetic Analysis of Valsartan in Healthy Chinese Subjects Explore how food affects absorption; liver enzymes and creatinine influence clearance in valsartan PopPK using…Certara2022 年 10 月 26 日
3 takeaways from the FDA oligo guidance you need to know Blog 3 takeaways from the FDA oligo guidance you need to know In June 2022, the FDA published their first oligonucleotide clinical pharmacology specific guidance . This…Certara2022 年 9 月 23 日